Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 9, 2024
Total Value: $1.924B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| QQQ | Invesco QQQ TR | 400,000 | $192M | 10.0% | — | — | Put | 46090E103 |
| NTRA | Natera Inc | 1,550,280 | $168M | 8.7% | $9.81 | +935.5% | COM | 632307104 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $101M | 5.3% | $15.35 | +158.4% | CL A | 92337R101 |
| ASND | Ascendis Pharma A/S | 734,284 | $100M | 5.2% | $92.54 | — | SPONSORED ADR | 04351P101 |
| NVO | Novo-Nordisk A S | 649,541 | $92.72M | 4.8% | $129.23 | — | ADR | 670100205 |
| EW | Edwards Lifesciences Corp | 724,225 | $66.9M | 3.5% | $88.55 | 0.0% | COM | 28176E108 |
| SYK | Stryker Corporation | 193,084 | $65.7M | 3.4% | $333.33 | 0.0% | COM | 863667101 |
| AZN | AstraZeneca PLC | 801,417 | $62.5M | 3.2% | $73.21 | — | SPONSORED ADR | 046353108 |
| DYN | Dyne Therapeutics Inc | 1,625,703 | $57.37M | 3.0% | $16.48 | +76.3% | COM | 26818M108 |
| ALGN | Align Technology Inc | 218,524 | $52.76M | 2.7% | $284.95 | -2.3% | COM | 016255101 |
| EW | Edwards Lifesciences Corp | 500,000 | $46.19M | 2.4% | $88.55 | 0.0% | Put | 28176E108 |
| RAPP | Rapport Therapeutics Inc | 1,951,562 | $45.39M | 2.4% | $23.15 | 0.0% | COM | 75383L102 |
| SNDX | Syndax Pharmaceuticals Inc | 2,153,669 | $44.21M | 2.3% | $21.11 | -0.9% | COM | 87164F105 |
| ELAN | Elanco Animal Health Inc | 2,864,250 | $41.33M | 2.1% | $13.99 | +14.2% | COM | 28414H103 |
| ABT | Abbott Labs | 390,200 | $40.55M | 2.1% | — | — | Call | 002824100 |
| IDYA | IDEAYA Biosciences Inc | 1,151,528 | $40.43M | 2.1% | $27.73 | +42.8% | COM | 45166A102 |
| ISRG | Intuitive Surgical Inc | 87,217 | $38.8M | 2.0% | $272.34 | +46.2% | COM | 46120E602 |
| ALNY | Alnylam Pharmaceuticals Inc | 147,929 | $35.95M | 1.9% | $164.10 | -3.8% | COM | 02043Q107 |
| TGTX | TG Therapeutics Inc | 1,861,277 | $33.11M | 1.7% | $15.93 | +0.2% | COM | 88322Q108 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $31.47M | 1.6% | $20.17 | -11.6% | COM | 04272N102 |
| IDXX | IDEXX Labs Inc | 63,862 | $31.11M | 1.6% | $546.49 | -8.1% | COM | 45168D104 |
| SRPT | Sarepta Therapeutics Inc | 195,852 | $30.94M | 1.6% | $122.50 | +4.9% | COM | 803607100 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $26.51M | 1.4% | $26.75 | — | COM | 984241109 |
| AXSM | Axsome Therapeutics Inc | 310,198 | $24.97M | 1.3% | $74.04 | 0.0% | COM | 05464T104 |
| COGT | Cogent Biosciences Inc | 2,773,286 | $23.38M | 1.2% | $6.37 | +19.1% | COM | 19240Q201 |
| XBI | Spdr Ser Tr | 250,000 | $23.18M | 1.2% | — | — | Put | 78464A870 |
| SLNO | Soleno Therapeutics Inc | 554,359 | $22.62M | 1.2% | $43.12 | -1.7% | COM | 834203309 |
| ISRG | Intuitive Surgical Inc | 50,000 | $22.24M | 1.2% | $272.34 | +46.2% | Put | 46120E602 |
| SVRA | Savara Inc | 5,358,918 | $21.6M | 1.1% | $4.15 | +7.2% | COM | 805111101 |
| CLDX | Celldex Therapeutics Inc | 547,707 | $20.27M | 1.1% | $33.15 | +13.8% | COM | 15117B202 |
| ROIV | Roivant Sciences Ltd | 1,868,412 | $19.75M | 1.0% | $10.86 | +0.9% | SHS | G76279101 |
| ESTA | Establishment Labs Hldgs Inc | 429,244 | $19.5M | 1.0% | $47.17 | +7.5% | COM | G31249108 |
| — | Inozyme Pharma Inc | 4,280,308 | $19.09M | 1.0% | $14.88 | — | COM | 45790W108 |
| RVMD | Revolution Medicines Inc | 455,099 | $17.66M | 0.9% | $37.38 | 0.0% | COM | 76155X100 |
| KURA | Kura Oncology Inc | 825,243 | $16.99M | 0.9% | $14.03 | +46.5% | COM | 50127T109 |
| INSM | Insmed Inc | 227,747 | $15.26M | 0.8% | $38.78 | 0.0% | COM PAR $.01 | 457669307 |
| BSX | Boston Scientific Corp | 171,080 | $13.17M | 0.7% | $60.26 | +21.5% | COM | 101137107 |
| MDGL | Madrigal Pharmaceuticals Inc | 44,417 | $12.44M | 0.6% | $237.01 | +0.4% | COM | 558868105 |
| PODD | Insulet Corp | 60,967 | $12.3M | 0.6% | $185.20 | -2.7% | COM | 45784P101 |
| ALNY | Alnylam Pharmaceuticals Inc | 50,000 | $12.15M | 0.6% | $164.10 | -3.8% | Call | 02043Q107 |
| PHVS | Pharvaris N V | 601,534 | $11.31M | 0.6% | $21.02 | -3.2% | COM | N69605108 |
| — | Axonics Inc | 150,490 | $10.12M | 0.5% | $68.97 | — | COM | 05465P101 |
| IMTX | Immatics N.V | 796,704 | $9.258M | 0.5% | $9.86 | +14.3% | SHS | N44445109 |
| CABA | Cabaletta Bio Inc | 1,220,400 | $9.129M | 0.5% | $13.86 | -11.6% | COM | 12674W109 |
| PEPG | PepGen Inc | 561,128 | $8.956M | 0.5% | $11.81 | +21.4% | COM | 713317105 |
| EWTX | Edgewise Therapeutics Inc | 475,691 | $8.567M | 0.4% | $17.44 | 0.0% | COM | 28036F105 |
| IMNM | Immunome Inc | 655,680 | $7.934M | 0.4% | $19.86 | -21.2% | COM | 45257U108 |
| EXAS | Exact Sciences Corp | 181,828 | $7.682M | 0.4% | $63.25 | -13.0% | COM | 30063P105 |
| — | Inari Med Inc | 155,838 | $7.504M | 0.4% | $48.14 | — | COM | 45332Y109 |
| DXCM | Dexcom Inc | 61,494 | $6.972M | 0.4% | $126.43 | 0.0% | COM | 252131107 |
| INBX | Inhibrx Biosciences Inc | 463,315 | $6.565M | 0.3% | $15.62 | 0.0% | COM | 45720N103 |
| ACHV | Achieve Life Sciences Inc | 1,388,372 | $6.525M | 0.3% | $4.44 | +8.5% | COM | 004468500 |
| WAT | Waters Corp | 21,804 | $6.326M | 0.3% | $319.12 | 0.0% | COM | 941848103 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $6.239M | 0.3% | $22.83 | — | COM | 008064107 |
| FDMT | 4D Molecular Therapeutics Inc | 271,155 | $5.692M | 0.3% | $25.40 | -1.2% | COM | 35104E100 |
| — | Marinus Pharmaceuticals Inc | 4,151,576 | $4.857M | 0.3% | $3.70 | — | COM | 56854Q200 |
| — | Nextcure Inc | 2,671,856 | $4.248M | 0.2% | $10.01 | — | COM | 65343E108 |
| ERAS | Erasca Inc | 1,699,528 | $4.011M | 0.2% | $2.16 | 0.0% | COM | 29479A108 |
| PAHC | Phibro Animal Health Corp | 237,009 | $3.975M | 0.2% | $16.07 | 0.0% | CL A COM | 71742Q106 |
| BAX | Baxter Intl Inc | 117,769 | $3.939M | 0.2% | $36.10 | -1.6% | COM | 071813109 |
| AVTR | Avantor Inc | 141,045 | $2.99M | 0.2% | $23.79 | +1.2% | COM | 05352A100 |
| TFX | Teleflex Incorporated | 13,649 | $2.871M | 0.1% | $230.54 | -10.5% | COM | 879369106 |
| MASI | Masimo Corp | 20,161 | $2.539M | 0.1% | $106.13 | +24.1% | COM | 574795100 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $2.066M | 0.1% | $32.91 | — | COM | 097702104 |
| INSP | Inspire Med Sys Inc | 10,000 | $1.338M | 0.1% | $194.73 | -2.8% | COM | 457730109 |
| IRON | Disc Medicine Inc | 29,256 | $1.319M | 0.1% | $40.49 | -16.1% | COM | 254604101 |
| CATX | Perspective Therapeutics Inc | 132,089 | $1.317M | 0.1% | $14.46 | 0.0% | COM | 46489V302 |
| ZBH | Zimmer Biomet Holdings Inc | 10,630 | $1.154M | 0.1% | $115.96 | 0.0% | COM | 98956P102 |
| LIVN | LivaNova PLC | 20,602 | $1.129M | 0.1% | $51.96 | +9.7% | SHS | G5509L101 |
| — | Immatics N.V | 348,731 | $933K | 0.0% | $3.46 | — | W EXP 07/01/2025 | N44445117 |
| RNAM | Avidity Biosciences Inc | 21,425 | $875K | 0.0% | $28.69 | 0.0% | COM | 05370A108 |
| — | Ikena Oncology Inc | 382,616 | $631K | 0.0% | $2.66 | — | COM | 45175G108 |
| SVRA | Savara Inc | 150,000 | $605K | 0.0% | $4.15 | +7.2% | Put | 805111101 |
| AMLX | Amylyx Pharmaceuticals Inc | 300,000 | $570K | 0.0% | $13.08 | -85.2% | Put | 03237H101 |
| AMLX | Amylyx Pharmaceuticals Inc | 299,691 | $569K | 0.0% | $13.08 | -85.2% | COM | 03237H101 |
| — | Astria Therapeutics Inc | 60,692 | $552K | 0.0% | $9.10 | — | COM | 04635X102 |
| PDSB | PDS Biotechnology Corp | 142,635 | $418K | 0.0% | $8.36 | -61.7% | COM | 70465T107 |
| LUNG | Pulmonx Corp | 60,246 | $382K | 0.0% | $7.69 | 0.0% | COM | 745848101 |
| KYTX | Kyverna Therapeutics Inc | 47,850 | $359K | 0.0% | $17.90 | -14.7% | COM | 501976104 |
| GPCR | Structure Therapeutics Inc | 8,915 | $350K | 0.0% | $50.19 | — | SPONSORED ADS | 86366E106 |
| — | Marinus Pharmaceuticals Inc | 104,700 | $122K | 0.0% | $3.70 | — | Call | 56854Q200 |